Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies by Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jurriaan E. M. de Steenwinkel, Andreas H. Diacon, Ulrika S. H. Simonsson, Shashikant Srivastava, Sebastian G. Wicha

Get full text

Barriers to Optimal Tuberculosis Treatment Services at Community Health Centers: A Qualitative Study From a High Prevalent Tuberculosis Country by Ivan S. Pradipta, Ivan S. Pradipta, Lusiana R. Idrus, Lusiana R. Idrus, Ari Probandari, Ari Probandari, Irma Melyani Puspitasari, Irma Melyani Puspitasari, Prayudi Santoso, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Eelko Hak

Get full text

Precision Therapy for Invasive Fungal Diseases by Anne-Grete Märtson, Jan-Willem C. Alffenaar, Roger J. Brüggemann, William Hope

Get full text

Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill by Asad E. Patanwala, Danijela Spremo, Minji Jeon, Yann Thoma, Jan-Willem C. Alffenaar, Sophie Stocker

Get full text

Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use? by Jan-Willem C. Alffenaar, Onno W. Akkerman, Hannah Yejin Kim, Simon Tiberi, Giovanni Battista Migliori

Get full text

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams by Jan-Willem C. Alffenaar, Arianna D. Pranger, Mathieu S. Bolhuis, Jos G. W. Kosterink, Prashant N. Panday

Get full text

Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment by Giovanni Sotgiu, Jan-Willem C. Alffenaar, Rosella Centis, Lia D’Ambrosio, Antonio Spanevello, Andrea Piana, Giovanni Battista Migliori

Get full text

Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy by Eman Wehbe, Asad E. Patanwala, Christine Y. Lu, Hannah Yejin Kim, Sophie L. Stocker, Jan-Willem C. Alffenaar

Get full text

Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective by Ivan S. Pradipta, Lusiana R. Idrus, Ari Probandari, Bony W. Lestari, Ajeng Diantini, Jan-Willem C. Alffenaar, Eelko Hak

Get full text

A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries by Patrizia Pignatti, Dina Visca, Stelios Loukides, Anne-Grete Märtson, Jan-Willem C. Alffenaar, Giovanni Battista Migliori, Antonio Spanevello

Get full text

Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients by Dyah Aryani Perwitasari, Endang Darmawan, Ully Adhi Mulyani, Pieter Van Der Vlies, Jan-Willem C Alffenaar, Jarir Atthobar, Bob Wilffert

Get full text

Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring by Mathieu S Bolhuis, Onno W Akkerman, Marieke G.G Sturkenboom, Wiel C.M de Lange, Tjip S van der Werf, Jan-Willem C Alffenaar

Get full text

Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study by Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan-Willem C. Alffenaar, Marieke G. G. Sturkenboom, Cecile Magis-Escurra

Get full text

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole by Sylvia D. Klomp, Anette Veringa, Jan‐Willem C. Alffenaar, Mark G. J. deBoer, Lambert F. R. Span, Henk‐Jan Guchelaar, Jesse J. Swen

Get full text

Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review by Hans Blokzijl, Anne-Grete Märtson, Martijn Bakker, Erik A M Verschuuren, Stefan P Berger, Lambert F R Span, Tjip S van der Werf, Jan-Willem C Alffenaar

Get full text

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients. by Marcel Hoppentocht, Onno W Akkerman, Paul Hagedoorn, Jan-Willem C Alffenaar, Tjip S van der Werf, Huib A M Kerstjens, Henderik W Frijlink, Anne H de Boer

Get full text

Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study by H Marike Boezen, Yuanyuan Wang, Bob Wilffert, Eelko Hak, Jan-Willem C Alffenaar, Jens H Bos, J F M van Boven, Catharina C M Schuiling-Veninga

Get full text

Correlation of drug exposure and bacterial susceptibility with treatment response for Mycobacterium avium complex lung disease: protocol for a prospective observational cohort stud... by Li Wang, Yi Hu, Jan-Willem C Alffenaar, Judith Bruchfeld, Wei Sha, Lina Davies Forsman, Xubin Zheng, Biao Xu, Yangyi Zhang, Yuhang Chen, Xuejiao Luo, Yidian Liu

Get full text

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis by Shulan Dong, Ge Shao, Lina Davies Forsman, Sainan Wang, Shanshan Wang, Jiayi Cao, Ziwei Bao, Judith Bruchfeld, Jan-Willem C. Alffenaar, Jia Liu, Yi Hu, Meiying Wu

Get full text

Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShor... by Mats Fredrikson, Jan-Willem C Alffenaar, Björn Carlsson, Katarina Niward, Jakob Paues, Ulrika S H Simonsson, David Ekqvist, Anna Bornefall, Daniel Augustinsson, Martina Sönnerbrandt, Michaela Jonsson Nordvall, Mårten Sandstedt

Get full text